Trial Profile
Naloxone nasal spray for opioid abuse
Status:
Planning
Phase of Trial:
Phase III
Latest Information Update: 27 May 2014
Price :
$35
*
At a glance
- Drugs Naloxone (Primary)
- Indications Opioid-related disorders
- Focus Registrational; Therapeutic Use
- 27 May 2014 New trial record
- 21 May 2014 Intranasal naloxone is entering its final clinical trial in June, according to an AntiOp media release.